GHRP-6 is an injectable peptide belonging to the growth hormone-releasing peptide (GHRP) class. The most common use of these peptide hormones is to increase the production of growth hormone (GH). Other peptides in the GHRP family include GHRP-2, hexarelin, and ipamorelin. In terms of boosting GH production, they are roughly comparable in efficacy. Moreover, there is neither a need nor a benefit to combining the use of different GHRP peptides; the optimal approach is to select the one best suited to your current condition and objectives.
The primary purpose of GHRP-6 is to elevate GH levels, which in turn increases insulin-like growth factor 1 (IGF-1) levels. This helps reduce body fat and, in some cases, leads to muscle gain. GHRP-6 is used more frequently than other GHRPs due to its appetite-stimulating effect (though this can also be a drawback). It also offers unique value in reducing inflammation and aiding in the treatment of injuries, particularly tendinitis.
The purposes of GHRP-6 use are generally the same as those of growth hormone (GH), including reducing body fat, enhancing muscle gains when using anabolic steroids, improving skin quality, and promoting wound healing.
There is no need to cycle GHRPs. Therefore, you can incorporate GHRP-6 into your routine at any time. However, if you are preparing for a competition, I recommend limiting the dosage to the lower end of the recommended range.
GHRP-6 is typically available commercially in 5mg vials and requires refrigeration. Reconstitute the powder in the vial with sterile water for injection. For example, dissolving one 5mg vial of GHRP-6 with 2.5mL of sterile water for injection results in a solution with a concentration of 2mg/mL (2000mcg/mL).
When administering, draw the required dosage using a disposable insulin syringe. In the example above, a 100mcg dose requires only 0.05mL, which is marked as "5 IU" on an insulin syringe. A 300mcg dose requires 0.15mL, or "15 IU" as indicated on the syringe.
Injections can be given subcutaneously or intramuscularly based on individual preference.
The recommended usage of GHRP-6 is three times daily. The optimal injection time is 30–60 minutes before meals, and it should be administered when blood glucose levels are not elevated. The general dosage ranges from 50–300mcg per injection. If used in combination with GHRH (Growth Hormone-Releasing Hormone), the dosage should be reduced to 50–100mcg per injection.
While GHRP-6 alone can significantly increase growth hormone (GH) production, studies have shown that the administration of a certain amount of GHRH (Growth Hormone-Releasing Hormone) can markedly enhance GHRP-6’s stimulatory effect on GH secretion. On the other hand, when GHRH is combined with GHRP-6, only approximately half or one-third of the standard GHRP-6 dosage is required to achieve the same level of GH elevation. Thus, combining GHRH with GHRP is a common choice, though excellent results can typically still be obtained without doing so. The preferred GHRH option is CJC-1925.
For boosting GH levels, GHRP-6 is less effective under conditions of high blood glucose or high somatostatin levels, which are induced by elevated IGF-1 (Insulin-like Growth Factor 1) levels. Therefore, the optimal time to use GHRP-6 is when blood glucose is relatively low—for example, 30–60 minutes before meals. If exogenous GH has been injected, GHRP-6’s efficacy will be diminished, as GH increases IGF-1 levels. Consequently, GHRP-6 administration should be timed to avoid overlapping with hGH (human Growth Hormone) use.
Low thyroxine levels can also reduce GHRP-6’s effectiveness. Therefore, moderate increases in thyroxine levels may improve its efficacy—for instance, 12.5–50mcg of T3 (triiodothyronine) per day.
GHRP-6 can effectively boost GH production. It is typically used 3–5 times daily, administered when blood glucose is stable, and is considerably more cost-effective than hGH. The only common potential side effect is increased appetite. Popular alternatives include GHRP-2, hexarelin, ipamorelin, or hGH itself.